Aviezer David

CIK 00013851121 companyCARMIEL, L3

SEC Profile

Transactions

Companies

Filings

CIK

0001385112

Recent Transactions

32 trades

Award
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2012-07-16+418,000→ 418,000 total
Exercise/Conversion
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2012-05-02$0.97/sh+123,733→ 450,000 total
Sale
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2012-05-02$7.13/sh−450,000→ 0 total
Exercise/Conversion
Protalix BioTherapeutics, Inc.$PLX
Stock Options (Right to Buy)
2012-05-02−326,267→ 0 total
Exercise/Conversion
Protalix BioTherapeutics, Inc.$PLX
Stock Options (Right to Buy)
2012-05-02−123,733→ 853,563 total
Exercise/Conversion
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2012-05-02$0.12/sh+326,267→ 326,267 total
Award
Protalix BioTherapeutics, Inc.$PLX
Stock Options (Right to Buy)
2010-02-25+250,000→ 250,000 total
Tax Payment
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2009-10-21$9.13/sh−3,253→ 0 total
Exercise/Conversion
Protalix BioTherapeutics, Inc.$PLX
Stock Options (Right to Buy)
2009-10-21−247,490→ 326,267 total
Sale
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2009-10-21$9.36/sh−34,238→ 0 total
Exercise/Conversion
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2009-10-21$0.12/sh+247,490→ 0 total
Sale
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2009-10-20$9.45/sh−60,000→ 0 total
Sale
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2009-10-19$9.43/sh−150,000→ 0 total
Sale
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2009-05-12$3.41/sh−55,900→ 0 total
Tax Payment
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2009-05-12$3.48/sh−3,571→ 0 total
Exercise/Conversion
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2009-05-12$0.12/sh+103,571→ 0 total
Exercise/Conversion
Protalix BioTherapeutics, Inc.$PLX
Stock Options (Right to Buy)
2009-05-12−103,571→ 573,757 total
Sale
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2009-05-11$3.41/sh−38,900→ 0 total
Sale
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2009-05-08$3.40/sh−5,200→ 0 total
Exercise/Conversion
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2009-05-06$0.12/sh+78,061→ 0 total
Sale
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2009-05-06$3.01/sh−20,000→ 0 total
Tax Payment
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2009-05-06$3.06/sh−3,061→ 0 total
Exercise/Conversion
Protalix BioTherapeutics, Inc.$PLX
Stock Options (Right to Buy)
2009-05-06−78,061→ 677,328 total
Sale
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2009-05-05$3.07/sh−21,600→ 0 total
Sale
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2009-05-04$3.01/sh−33,400→ 0 total
Exercise/Conversion
Protalix BioTherapeutics, Inc.$PLX
Stock Options (Right to Buy)
2009-04-20−52,469→ 755,389 total
Tax Payment
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2009-04-20$2.55/sh−2,469→ 0 total
Exercise/Conversion
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2009-04-20$0.12/sh+52,469→ 0 total
Sale
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2009-04-20$2.51/sh−33,300→ 0 total
Sale
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2009-04-17$2.56/sh−10,000→ 0 total
Sale
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2009-04-16$2.50/sh−6,700→ 0 total
Award
Protalix BioTherapeutics, Inc.$PLX
Stock Options (Right to Buy)
2009-02-25+100,000→ 100,000 total

Companies

Protalix BioTherapeutics, Inc.
Director, President & CEO
$PLX

Recent Filings

Address

C/O PROTALIX BIOTHERAPEUTICS, INC. 2 SNUNIT STREET, SCIENCE PARK, POB 455

CARMIEL, L3, 20100

View on SEC.gov